Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Swartz

Showing results (241-250 of 265) with videos related to

Pageof 27
Sort By:
Biological Psychiatry|July 31, 2009
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness studyJonathan M Meyer, Joseph P McEvoy, Vicki G Davis, et al.
Psychiatric Services (Washington, D.C.)|July 28, 2006
Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
JAMA|May 22, 2014
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trialJoseph P McEvoy, Matthew Byerly, Robert M Hamer, et al.
Psychiatric Services (Washington, D.C.)|June 11, 2020
Mental Health Policy in the Era of COVID-19Matthew L Goldman, Benjamin G Druss, Marcela Horvitz-Lennon, et al.
Biochemistry|August 30, 2013
DEER EPR measurements for membrane protein structures via bifunctional spin labels and lipodisq nanoparticlesIndra D Sahu, Robert M McCarrick, Kaylee R Troxel, et al.
Schizophrenia Research|May 13, 2011
Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE studyT Scott Stroup, Paul S Appelbaum, Hongbin Gu, et al.
Preventive Medicine|October 3, 2022
Gun violence among young adults with a juvenile crime record in North Carolina: Implications for firearm restrictions based on age and riskJeffrey W Swanson, Guangyu Tong, Michele M Easter, et al.
Schizophrenia Research|June 7, 2008
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1Jonathan M Meyer, Vicki G Davis, Joseph P McEvoy, et al.
The American Journal of Psychiatry|April 6, 2006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychoticT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
The American Journal of Psychiatry|March 3, 2007
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE studyT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Pageof 27

Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
Biological Psychiatry|July 31, 2009
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness studyJonathan M Meyer, Joseph P McEvoy, Vicki G Davis, et al.
Psychiatric Services (Washington, D.C.)|July 28, 2006
Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
JAMA|May 22, 2014
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trialJoseph P McEvoy, Matthew Byerly, Robert M Hamer, et al.
Psychiatric Services (Washington, D.C.)|June 11, 2020
Mental Health Policy in the Era of COVID-19Matthew L Goldman, Benjamin G Druss, Marcela Horvitz-Lennon, et al.
Biochemistry|August 30, 2013
DEER EPR measurements for membrane protein structures via bifunctional spin labels and lipodisq nanoparticlesIndra D Sahu, Robert M McCarrick, Kaylee R Troxel, et al.
Schizophrenia Research|May 13, 2011
Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE studyT Scott Stroup, Paul S Appelbaum, Hongbin Gu, et al.
Preventive Medicine|October 3, 2022
Gun violence among young adults with a juvenile crime record in North Carolina: Implications for firearm restrictions based on age and riskJeffrey W Swanson, Guangyu Tong, Michele M Easter, et al.
Schizophrenia Research|June 7, 2008
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1Jonathan M Meyer, Vicki G Davis, Joseph P McEvoy, et al.
The American Journal of Psychiatry|April 6, 2006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychoticT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
The American Journal of Psychiatry|March 3, 2007
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE studyT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Pageof 27